Neurocrine Biosciences Q1 Beats on Earnings, Revenue

Neurocrine Biosciences Q1 Beats on Earnings, Revenue

Source: 
Motley Fool
News Tags: 
snippet: 

Investors rewarded Neurocrine Biosciences (NASDAQ: NBIX) on Wednesday for posting a Q1 of fiscal 2020 earnings report that featured encouraging growth in key financials.